NON-MUSCLE INVASIVE BLADDER CANCER
Clinical trials for NON-MUSCLE INVASIVE BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER CANCER trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to shrink bladder tumors before surgery
Disease control CompletedThis study tested if taking a targeted pill called pemigatinib for 4-6 weeks could shrink or eliminate recurrent, non-invasive bladder tumors before standard surgery. It involved 30 patients with a history of low- or intermediate-risk tumors that had come back. The main goal was …
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New bladder cancer surgery technique aims to reduce recurrence
Disease control CompletedThis study compared two surgical techniques for removing early-stage bladder tumors that haven't spread into the muscle. Researchers wanted to see if removing the tumor in one intact piece (en bloc TURBT) leads to fewer cancer returns than the standard method of removing it in mu…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER
Phase: NA • Sponsor: Lahore General Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New bladder cancer surgery technique aims to reduce tumor recurrence
Disease control CompletedThis study compared two surgical methods for removing early-stage bladder tumors that haven't spread into the muscle wall. Researchers tested whether removing the entire tumor in one piece (En Bloc) leads to better diagnosis and fewer cancer returns compared to the standard metho…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER
Phase: NA • Sponsor: Jørgen Bjerggaard Jensen • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New bladder cancer drug tested for safety in early trial
Disease control CompletedThis early-stage study tested the safety of a new drug called UGN-301 for people with recurring non-muscle invasive bladder cancer. The drug was delivered directly into the bladder, both by itself and combined with other treatments. The main goal was to find a safe dose and under…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER
Phase: PHASE1 • Sponsor: UroGen Pharma Ltd. • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Simple urine test vs. uncomfortable scope: which do bladder cancer patients prefer?
Diagnosis CompletedThis study aimed to find out whether people with non-muscle invasive bladder cancer prefer a simple urine test or a traditional scope procedure for monitoring their condition. Researchers asked 107 patients who tried both methods about their preferences, satisfaction, and quality…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Mar 27, 2026 12:40 UTC